MDCO Sues Again For Extension Of Angiomax Patent
The Medicines Co. has again sued the U.S. Patent and Trademark Office, seeking to set aside the agency's second denial of an application to extend the principal U.S. patent covering anti-coagulant...To view the full article, register now.
Already a subscriber? Click here to view full article